Showing results (441-450 of 565) with videos related to
Sort By:
Pageof 57
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 28, 2018
Utilization of stress testing for low-risk patients with chest discomfort in the emergency departmentSheela Krishnan, Rachael Venn, Daniel M Blumenthal, et al.The Oncologist|March 13, 2020
An Analysis of Recent FDA Oncology Scientific PublicationsJulie A Schneider, Andrew C Miklos, James Onken, et al.JAMA Oncology|June 16, 2017
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials: A Meta-analysisGideon M Blumenthal, Lijun Zhang, Hui Zhang, et al.Plos One|March 1, 2019
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancerTristan M Sissung, Arun Rajan, Gideon M Blumenthal, et al.Clinical Trials (London, England)|March 19, 2019
Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directionsBellinda L King-Kallimanis, Lynn J Howie, Jessica K Roydhouse, et al.Environmental Health Perspectives|October 1, 1987
Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986L S Gold, T H Slone, G M Backman, et al.Nucleic Acids Research|April 20, 2021
Preferential CEBP binding to T:G mismatches and increased C-to-T human somatic mutationsJie Yang, John R Horton, Kadir C Akdemir, et al.The Journal of Biological Chemistry|February 21, 2022
Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAsDan Yu, Nan Dai, Eric J Wolf, et al.The New Phytologist|September 17, 2013
Invasive forb benefits from water savings by native plants and carbon fertilization under elevated CO2 and warmingDana M Blumenthal, Víctor Resco, Jack A Morgan, et al.Clinical Pharmacology and Therapeutics|February 14, 2015
The role of nonrandomized trials in the evaluation of oncology drugsR Simon, G M Blumenthal, M L Rothenberg, et al.Pageof 57